Stockreport

Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline [Yahoo! Finance]

Janus Henderson Group plc Ordinary Shares  (JHG) 
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am Check Earnings Report
US:NYSE Investor Relations: snl.com/irw/corporateprofile/4147331
PDF Capital, Balyasny Asset Management L.P., Woodline Partners LP and all existing investors Proceeds to fund clinical development of DIAG723, a first-in-class, disease-mo [Read more]